Nine major European drugmakers warn the region risks losing pharma investment, Novartis licenses a preclinical radioligand ...

The best CI partner isn't the one with the most data — it's the one willing to tell you your assumptions are wrong. Pharma ...

Chief executives from nine of Europe's largest drugmakers are calling on the European Union (EU) and its member states to ...

BoomRay Pharmaceuticals entered into an exclusive global license agreement with Novartis for an undisclosed preclinical ...

The FDA's movement to encourage real-world data use through downstream acceptance is, in effect, a call to action for sponsors to begin exploring — if they haven't already — how to use it upstream as ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

Novo Nordisk reports that CagriSema delivered 12.4% average weight loss in a late-stage diabetes trial, outperforming tirzepatide's 9.1% at comparable doses.

GSK is acquiring a trispecific T-cell engager from Chimagen Biosciences and Sanofi expanding its manufacturing partnership ...

AbbVie partners with Iambic to deploy its AI molecular superintelligence platform, while Telix Pharmaceuticals agrees to acquire radioisotope leader ITM.

As GLP-1 competition shifts from molecules to prescriptions, manufacturers, pharmacies, providers, and payers are racing to ...

FDA approves Kerendia as the first new treatment for kidney disease in type 1 diabetes in decades, Novo, Roche, and Aethlon ...

Orbis Medicines announced a strategic collaboration and license agreement with Novo to discover and develop next-generation ...